Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases.
Soscia R, Della Starza I, De Novi LA, Ilari C, Ansuinelli M, Cavalli M, Bellomarino V, Cafforio L, Di Trani M, Cazzaniga G, Fazio G, Santoro A, Salemi D, Spinelli O, Tosi M, Terragna C, Robustelli V, Bellissimo T, Colafigli G, Breccia M, Chiaretti S, Di Rocco A, Martelli M, Guarini A, Del Giudice I, Foà R. Soscia R, et al. Among authors: spinelli o. Hematol Oncol. 2023 Feb;41(1):50-60. doi: 10.1002/hon.3087. Epub 2022 Oct 19. Hematol Oncol. 2023. PMID: 36251440
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
Spinelli O, Peruta B, Tosi M, Guerini V, Salvi A, Zanotti MC, Oldani E, Grassi A, Intermesoli T, Micò C, Rossi G, Fabris P, Lambertenghi-Deliliers G, Angelucci E, Barbui T, Bassan R, Rambaldi A. Spinelli O, et al. Haematologica. 2007 May;92(5):612-8. doi: 10.3324/haematol.10965. Haematologica. 2007. PMID: 17488684 Free article.
Prognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemia.
Spinelli O, Tosi M, Peruta B, Guinea Montalvo ML, Maino E, Scattolin AM, Parolini M, Viero P, Rambaldi A, Bassan R. Spinelli O, et al. Mediterr J Hematol Infect Dis. 2014 Sep 1;6(1):e2014062. doi: 10.4084/MJHID.2014.062. eCollection 2014. Mediterr J Hematol Infect Dis. 2014. PMID: 25237475 Free PMC article. Review.
In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent.
Baccarani M, Iacobucci I, Chiaretti S, Foà' R, Balasubramanian P, Paietta E, Foroni L, Jeromin S, Izzo B, Spinelli O, Varma N, Menif S, Terragna C, Seth T, Bidet A, Coriu D, Lunghi F, Mayer J, Scappini B, Langabeer S, Maier J, Burt E, Candoni A, Albano F, Luppi M, Zupan I, Lion T, Zadro R, di Raimondo F, Poopak B, Rege-Cambrin G, Annunziata M, Ayala A, Salinas-Viedma V, Ines Prado A, Milner B, Galimberti S, Janssen J, Polli V, Comba L, Borsellino B, Annibali O, Crugnola M, Passamonti F. Baccarani M, et al. Among authors: spinelli o. Leukemia. 2020 Mar;34(3):929-931. doi: 10.1038/s41375-019-0591-9. Epub 2019 Oct 8. Leukemia. 2020. PMID: 31595038 Free article. No abstract available.
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913.
Chiaretti S, Messina M, Della Starza I, Piciocchi A, Cafforio L, Cavalli M, Taherinasab A, Ansuinelli M, Elia L, Albertini Petroni G, La Starza R, Canichella M, Lauretti A, Puzzolo MC, Pierini V, Santoro A, Spinelli O, Apicella V, Capria S, Di Raimondo F, De Fabritiis P, Papayannidis C, Candoni A, Cairoli R, Cerrano M, Fracchiolla N, Mattei D, Cattaneo C, Vitale A, Crea E, Fazi P, Mecucci C, Rambaldi A, Guarini A, Bassan R, Foà R. Chiaretti S, et al. Among authors: spinelli o. Haematologica. 2021 Jun 1;106(6):1559-1568. doi: 10.3324/haematol.2020.247973. Haematologica. 2021. PMID: 32467145 Free PMC article.
Capture-based Next-Generation Sequencing Improves the Identification of Immunoglobulin/T-Cell Receptor Clonal Markers and Gene Mutations in Adult Acute Lymphoblastic Leukemia Patients Lacking Molecular Probes.
Cavagna R, Guinea Montalvo ML, Tosi M, Paris M, Pavoni C, Intermesoli T, Bassan R, Mosca A, Rambaldi A, Spinelli O. Cavagna R, et al. Among authors: spinelli o. Cancers (Basel). 2020 Jun 9;12(6):1505. doi: 10.3390/cancers12061505. Cancers (Basel). 2020. PMID: 32526928 Free PMC article.
Immature Immunoglobulin Gene Rearrangements Are Recurrent in B Precursor Adult Acute Lymphoblastic Leukemia Carrying TP53 Molecular Alterations.
Salmoiraghi S, Cavagna R, Guinea Montalvo ML, Ubiali G, Tosi M, Peruta B, Intermesoli T, Oldani E, Salvi A, Pavoni C, Giussani U, Bassan R, Rambaldi A, Spinelli O. Salmoiraghi S, et al. Among authors: spinelli o. Genes (Basel). 2020 Aug 20;11(9):960. doi: 10.3390/genes11090960. Genes (Basel). 2020. PMID: 32825230 Free PMC article.
Digital Droplet PCR Is a Reliable Tool to Improve Minimal Residual Disease Stratification in Adult Philadelphia-Negative Acute Lymphoblastic Leukemia.
Della Starza I, De Novi LA, Santoro A, Salemi D, Spinelli O, Tosi M, Soscia R, Paoloni F, Cappelli LV, Cavalli M, Apicella V, Bellomarino V, Di Lello E, Vitale A, Vignetti M, Fabbiano F, Rambaldi A, Bassan R, Guarini A, Chiaretti S, Foà R. Della Starza I, et al. Among authors: spinelli o. J Mol Diagn. 2022 Aug;24(8):893-900. doi: 10.1016/j.jmoldx.2022.04.014. Epub 2022 Jun 13. J Mol Diagn. 2022. PMID: 35710027 Free article.
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings.
Chiaretti S, Taherinasab A, Della Starza I, Canichella M, Ansuinelli M, De Propris MS, Messina M, Spinelli O, Santoro A, De Novi LA, Cardinali D, Schipani M, Arena V, Bassan R, Guarini A, Foà R. Chiaretti S, et al. Among authors: spinelli o. Leuk Lymphoma. 2023 Feb;64(2):483-486. doi: 10.1080/10428194.2022.2148217. Epub 2022 Dec 19. Leuk Lymphoma. 2023. PMID: 36533589 No abstract available.
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.
Bassan R, Chiaretti S, Della Starza I, Spinelli O, Santoro A, Paoloni F, Messina M, Elia L, De Propris MS, Scattolin AM, Audisio E, Marbello L, Borlenghi E, Zappasodi P, Mauro E, Martinelli G, Mattei D, Fracchiolla N, Bocchia M, De Fabritiis P, Bonifacio M, Candoni A, Cassibba V, Di Bartolomeo P, Latte G, Trappolini S, Guarini A, Vitale A, Fazi P, Piciocchi A, Rambaldi A, Foà R. Bassan R, et al. Among authors: spinelli o. Blood Adv. 2023 Aug 22;7(16):4448-4461. doi: 10.1182/bloodadvances.2022009596. Blood Adv. 2023. PMID: 37276451 Free PMC article.
109 results